Laureline Gatellier: First Day at ASNO2026 in Kanazawa
Laureline Gatellier/ Facebook

Laureline Gatellier: First Day at ASNO2026 in Kanazawa

Laureline Gatellier, Scientific Researcher at National Cancer Center Japan, shared a post on Facebook:

”First day at the Asian Society for Neuro-Oncology (ASNO) in Kanazawa, learning, reconnecting, and working together to improve the lives of people affected by brain tumors across Asia.

So impressed to learn in details the history of and evolution of gliomas and brain tumors treatment directly from the leaders who helped shape the field, including Dr Roger Stupp (whose landmark temozolomide paper from 2005 I read so many times), Dr Aldape on major updates of CNS tumor classification (c-Impact-NOW). And more…

And of course reconnecting with friends i respect so deeply, including Dr Peter Woo, Dr Rakesh Jalali, Melissa, and many others.

The manuscript i read so many times about Glioblastoma.”

Title: Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Authors: Roger Stupp, Warren P. Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin J. B. Taphoorn, Karl Belanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C. Janzer, Samuel K. Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J. Gregory Cairncross, Elizabeth Eisenhauer, René O. Mirimanoff

Read The Full Article.

Laureline Gatellier: First Day at ASNO2026 in Kanazawa

Other Articles About Brain Tumor on OncoDaily.